POLICY BRIEFINGS


Upcoming Congressional Meetings and Hearings


House Veterans’ Affairs Oversight and Investigations (O&I) Subcommittee: hearing titled “Circumvention of Contracts in the Provision of Non-VA Healthcare;” 4:00 p.m., 334 Cannon Bldg.; June 1

House Budget Committee: hearing titled “The Congressional Budget Office: Oversight Hearing;” 10:00 a.m., 210 Cannon Bldg.; June 3


Health Legislation Recently Introduced


H.R. 2391 (MEDICAID), to amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation; CUMMINGS; to the House Committee on Energy and Commerce; May 18

H.R. 2396 (HEALTH SOFTWARE), to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of health software, and for other purposes; BLACKBURN; to the House Committee on Energy and Commerce; May 18

H.R. 2400 (ACA), to establish the Office of the Special Inspector General for Monitoring the Affordable Care Act, and for other purposes; ROSKAM: jointly, to the committee on Energy and Commerce, Natural Resources, Education and the Workforce, Ways and Means, Oversight and Government Reform, House Administration, the Judiciary, Rules, and Appropriations; May 18

S.1364 (MEDICAID), to amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation; SANDERS; to the Committee on Finance; May 18

H.R. 6 (21st CENTURY CURES), to accelerate the discovery, development, and delivery of 21st century cures, and for other purposes; UPTON; jointly, to the committee on Energy and Commerce and Ways and Means; May 19

H.R. 2414 (MEDICAL DEVELOPMENTS), to facilitate the responsible communication of scientific and medical developments; BURGESS; to the Committee on Energy and Commerce; May 19

H.R. 2415 (DATA REVIEW), to amend the Federal Food, Drug, and Cosmetic Act to provide for establishment of a streamlined data review program; BURGESS; to the Committee on Energy and Commerce; May 19

H.R. 2416 (CLINICAL EXPERIENCE), to amend the Federal Food, Drug, and Cosmetic Act to evaluate the potential use of evidence from clinical experience to help support the approval of new indications for approved drugs, and for other purposes; BURGESS; to the Committee on Energy and Commerce; May 19

H.R. 2417 (MEDICAL SCHOOL), to amend the Higher Education Act of 1965 to establish fair and consistent eligibility requirements for graduate medical schools operating outside the United States and Canada; BURGESS; to the Committee on Education and the Workforce; May 19



May 26, 2015: | Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10

SERVICES




BRIEFING ARCHIVE


 -  2018


 +  2017


 +  2016


 +  2015


 +  2014


 +  2013


 +  2012


 +  2011